OFFIDANI, MASSIMO
 Distribuzione geografica
Continente #
NA - Nord America 1.196
AS - Asia 780
EU - Europa 642
SA - Sud America 200
Continente sconosciuto - Info sul continente non disponibili 82
AF - Africa 62
OC - Oceania 1
Totale 2.963
Nazione #
US - Stati Uniti d'America 1.153
VN - Vietnam 210
IT - Italia 200
SG - Singapore 194
BR - Brasile 145
CN - Cina 138
RU - Federazione Russa 124
HK - Hong Kong 106
DE - Germania 68
FR - Francia 52
CI - Costa d'Avorio 32
FI - Finlandia 32
GB - Regno Unito 32
AR - Argentina 27
IN - India 25
IE - Irlanda 23
SE - Svezia 23
UA - Ucraina 19
CA - Canada 18
JP - Giappone 17
TR - Turchia 17
NL - Olanda 15
AT - Austria 13
MX - Messico 13
BD - Bangladesh 12
EC - Ecuador 10
DK - Danimarca 9
MA - Marocco 9
SA - Arabia Saudita 8
ZA - Sudafrica 8
ID - Indonesia 7
IQ - Iraq 7
UZ - Uzbekistan 7
ES - Italia 6
CO - Colombia 5
PK - Pakistan 5
PL - Polonia 5
VE - Venezuela 5
HU - Ungheria 4
KR - Corea 4
SN - Senegal 4
BE - Belgio 3
CR - Costa Rica 3
JO - Giordania 3
LT - Lituania 3
MY - Malesia 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
IL - Israele 2
KE - Kenya 2
KZ - Kazakistan 2
NP - Nepal 2
PE - Perù 2
TN - Tunisia 2
TW - Taiwan 2
UY - Uruguay 2
AL - Albania 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CD - Congo 1
CH - Svizzera 1
CL - Cile 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GI - Gibilterra 1
LK - Sri Lanka 1
LU - Lussemburgo 1
PA - Panama 1
PH - Filippine 1
PR - Porto Rico 1
PT - Portogallo 1
RO - Romania 1
SV - El Salvador 1
TH - Thailandia 1
Totale 2.881
Città #
Ashburn 274
Dallas 131
Singapore 112
Hong Kong 102
San Jose 100
Council Bluffs 87
Ho Chi Minh City 76
Hanoi 48
Boardman 42
Los Angeles 35
The Dalles 34
Abidjan 32
Munich 31
Chandler 26
New York 26
Moscow 25
Beijing 24
Dublin 23
Lauterbourg 23
São Paulo 22
Helsinki 20
Milan 20
Rome 19
Hefei 18
Santa Clara 17
Frankfurt am Main 16
Jacksonville 15
Fairfield 14
Denver 13
Wilmington 12
Da Nang 11
Orem 11
Turin 11
Buffalo 10
Nuremberg 10
Seattle 10
Chennai 9
Turku 9
Brooklyn 8
Houston 8
Mexico City 8
Tokyo 8
Amsterdam 7
Ancona 7
Guangzhou 7
Bari 6
Chicago 6
Tashkent 6
Woodbridge 6
Bologna 5
Cambridge 5
Falconara Marittima 5
Haiphong 5
Johannesburg 5
Lawrence 5
London 5
Miami 5
Montreal 5
North Charleston 5
Phoenix 5
Princeton 5
Washington 5
Atlanta 4
Bowling Green 4
Brescia 4
Camden 4
Columbus 4
Dakar 4
Hải Dương 4
Ninh Bình 4
Piscataway 4
Rio de Janeiro 4
Warsaw 4
Ankara 3
Ann Arbor 3
Baghdad 3
Biên Hòa 3
Boston 3
Brussels 3
Buenos Aires 3
Caracas 3
Curitiba 3
Guayaquil 3
Holstebro 3
Huế 3
Magnesia ad Sipylum 3
Manchester 3
Medellín 3
Mumbai 3
New Delhi 3
Palermo 3
Pescara 3
Plano 3
Poplar 3
Quito 3
Quảng Ninh 3
San Mateo 3
Southwark 3
Stockbridge 3
Thái Bình 3
Totale 1.785
Nome #
Efficacy and feasibility of high-dose cytarabine plus idarubicin and amifostine as induction schedule: a prospective observational study of 100 AML elderly patients 160
Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma 145
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma 139
Real‐world assessment of treatment patterns and outcomes in patients with relapsed‐refractory multiple myeloma in an Italian haematological tertiary care centre 138
Comparison of isatuximab-pomalidomide-dexamethasone versus elotuzumab-pomalidomidedexamethasone in relapsed/refractory multiple myeloma patients: a target trial emulation using real-world data 132
Efficacy and Prognostic Indicators of Isatuximab, Pomalidomide, and Dexamethasone (IsaPd) in Daratumumab‐Refractory Multiple Myeloma Patients: A Multicenter Real‐World Study 131
NOVELTIES ON MULTIPLE MYELOMA FROM THE MAIN 2024 HEMATOLOGY CONFERENCES 129
Current Main Topics in Multiple Myeloma 127
Anticoagulation and vessel recanalization in cirrhotic patients with splanchnic vein thrombosis: A multidisciplinary “real life” experience 124
Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study 120
Prevalence of Type 1 Gaucher Disease in Patients with Multiple Myeloma: Updated Interim Analysis of a Prospective, Multicentre, Observational Study 117
Frequency and Risk Factors for Venous Thromboembolism Among Patients with Multiple Myeloma or Aggressive Lymphoma: A 6-Year Single Center Retrospective Analysis 111
Hepatic, gastric and bone marrow AL amyloidosis that began with Budd-Chiari syndrome: a case report 109
Clinical Presentation, Risk Factors and Outcome of Splanchnic Venous Thrombosis: A Report on 305 Cases 107
AL amyloidosis: an overview on diagnosis, staging system, and treatment 107
Belantamab Mafodotin for the Treatment of Multiple Myeloma: An Overview of the Clinical Efficacy and Safety 107
Novel Immunotherapies and Combinations: The Future Landscape of Multiple Myeloma Treatment 106
Long-Term Survival with Multiple Myeloma: An Italian Experience 103
Belantamab mafodotin in triple-refractory multiple myeloma patients: A retro-prospective observational study in Italy 101
Belantamab Mafodotin: From Clinical Trials Data to Real-Life Experiences 99
Prognostic Significance of +1q Alterations in Relapsed/Refractory Multiple Myeloma Treated With Daratumumab‐, Elotuzumab‐, and Carfilzomib‐Based Triplet Regimens: A Multicenter Real‐World Analysis of 635 Patients 98
Prevalence of type I Gaucher disease in patients with smoldering or multiple myeloma: Results from the prospective, observational CHAGAL study 97
The Challenging Approach to Multiple Myeloma: From Disease Diagnosis and Monitoring to Complications Management 85
Infection events in patients with newly diagnosed multiple myeloma with anti-CD38 monoclonal antibody-based first line regimens: A multicentric Italian experience 74
Cytogenetic Features and Their Implications in Clinical Practice: A Real-World Analysis of a Large Cohort of Multiple Myeloma Patients 70
Sequential Bispecific Antibodies in Functional and Clinical High Risk Multiple Myeloma, Manifesting with Extramedullary Disease at Relapse: A Case Report 69
Continous or fixedcarfilzomib, lenalidomide and dexamethasone (krd) for relapsed-refractory multiple myeloma: long-term follow-up from a multicenter, retrospective real-life surveyfrom European myeloma network (emn) Italy 58
Totale 2.963
Categoria #
all - tutte 10.860
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.860


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202230 0 3 2 1 0 1 5 3 1 2 6 6
2022/202387 5 11 7 3 4 11 0 4 18 0 24 0
2023/2024182 15 5 8 11 22 18 4 5 9 7 23 55
2024/2025549 40 27 21 6 12 33 40 25 130 80 57 78
2025/20261.868 145 135 169 174 188 179 367 145 107 152 61 46
2026/2027126 70 56 0 0 0 0 0 0 0 0 0 0
Totale 2.963